195 related articles for article (PubMed ID: 21481326)
1. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
[TBL] [Abstract][Full Text] [Related]
3. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
4. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the host response to a gamma-herpesvirus.
Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
[TBL] [Abstract][Full Text] [Related]
6. Immunisation of Balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity.
Morley PJ; Ertl P; Sweet C
J Med Virol; 2002 Jun; 67(2):187-99. PubMed ID: 11992579
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon.
Aricò E; Robertson K; Allen D; Ferrantini M; Belardelli F; Nash AA
J Interferon Cytokine Res; 2002 Nov; 22(11):1081-8. PubMed ID: 12513907
[TBL] [Abstract][Full Text] [Related]
8. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.
Dutia BM; Allen DJ; Dyson H; Nash AA
Virology; 1999 Sep; 261(2):173-9. PubMed ID: 10497103
[TBL] [Abstract][Full Text] [Related]
9. MHV-68 Open Reading Frame 20 is a nonessential gene delaying lung viral clearance.
Nascimento R; Costa H; Dias JD; Parkhouse RM
Arch Virol; 2011 Mar; 156(3):375-86. PubMed ID: 21104281
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load.
Hoegh-Petersen M; Thomsen AR; Christensen JP; Holst PJ
Vaccine; 2009 Nov; 27(48):6723-30. PubMed ID: 19748577
[TBL] [Abstract][Full Text] [Related]
11. Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.
Willer DO; Speck SH
J Virol; 2005 Mar; 79(5):2891-9. PubMed ID: 15709008
[TBL] [Abstract][Full Text] [Related]
12. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
[TBL] [Abstract][Full Text] [Related]
13. Pathogenetical characterization of isolate MHV-60 of mouse herpesvirus strain 68.
Pappová M; Stanceková M; Spissáková I; Durmanová V; Mistríková J
Acta Virol; 2004; 48(2):91-6. PubMed ID: 15462284
[TBL] [Abstract][Full Text] [Related]
14. Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation.
Haas F; Yamauchi K; Murat M; Bernasconi M; Yamanaka N; Speck RF; Nadal D
J Virol; 2014 Sep; 88(17):10002-12. PubMed ID: 24942583
[TBL] [Abstract][Full Text] [Related]
15. Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection.
Rickabaugh TM; Brown HJ; Martinez-Guzman D; Wu TT; Tong L; Yu F; Cole S; Sun R
J Virol; 2004 Sep; 78(17):9215-23. PubMed ID: 15308716
[TBL] [Abstract][Full Text] [Related]
16. The anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection.
Leang RS; Wu TT; Hwang S; Liang LT; Tong L; Truong JT; Sun R
PLoS Pathog; 2011 Oct; 7(10):e1002292. PubMed ID: 21998588
[TBL] [Abstract][Full Text] [Related]
17. Myocarditis in newborn wild-type BALB/c mice infected with the murine gamma herpesvirus MHV-68.
Häusler M; Sellhaus B; Scheithauer S; Gaida B; Kuropka S; Siepmann K; Panek A; Berg W; Teubner A; Ritter K; Kleines M
Cardiovasc Res; 2007 Nov; 76(2):323-30. PubMed ID: 17658501
[TBL] [Abstract][Full Text] [Related]
18. Prospects of a novel vaccination strategy for human gamma-herpesviruses.
Wu TT; Blackman MA; Sun R
Immunol Res; 2010 Dec; 48(1-3):122-46. PubMed ID: 20717741
[TBL] [Abstract][Full Text] [Related]
19. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
Samreen B; Tao S; Tischer K; Adler H; Drexler I
Front Immunol; 2019; 10():2984. PubMed ID: 31921215
[TBL] [Abstract][Full Text] [Related]
20. In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences.
El-Gogo S; Flach B; Staib C; Sutter G; Adler H
Virology; 2008 Oct; 380(2):322-7. PubMed ID: 18774154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
